SCM
IDXG

Stonepine Capital Management’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Stonepine Capital Management’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-284,730
Closed -$880K – 24
2020
Q3 		$880K Buy
+284,730
New +$1.29M 0.92% 16
2020
Q2 		– Sell
-178,295
Closed -$924K – 28
2020
Q1 		$924K Buy
178,295
+83,910
+89% +$608K 0.98% 24
2019
Q4 		$472K Sell
94,385
-21,653
-19% -$140K 0.33% 21
2019
Q3 		$922K Sell
116,038
-59,280
-34% -$463K 0.89% 19
2019
Q2 		$1.27M Buy
175,318
+31,915
+22% +$234K 0.88% 21
2019
Q1 		$1.15M Buy
+143,403
New +$1.35M 0.66% 26

Other funds holding IDXG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return